Navigation Links
Positive Mid-Term Results on CryoValve(R) SG Pulmonary Human Heart Valve Presented at Western Thoracic Meeting
Date:6/30/2008

ATLANTA, June 30 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), a biomaterials, medical device and tissue processing company, has announced that positive mid-term performance data on the CryoValve(R) SG decellularized pulmonary human heart valve were presented on June 28th at the 34th Annual Western Thoracic Surgical Association Meeting in Kona, Hawaii. The data, used earlier this year to support the marketing clearance for the valve, were presented by John W. Brown, M.D., professor of Cardiothoracic Surgery, Indiana University School of Medicine.

For the study, 342 patients who received a CryoValve SG processed using CryoLife's proprietary SynerGraft(R) technology were compared to 1,246 patients who received a conventionally processed CryoValve pulmonary heart valve. All patients received the valves in conjunction with either a right ventricular outflow tract (RVOT) reconstruction or as part of the Ross Procedure, which is described below. Average follow-up time was 3.9 years for the CryoValve SG RVOT procedure patients, and 4.7 years for the Ross Procedure patients. The average follow-up times were comparable for patients who received the conventionally processed CryoValve.

The results showed that there was a statistically significant reduction in structural valve deterioration -- SVD (71 percent actuarial freedom from SVD at five years for CryoValve SG versus 55 percent for CryoValve) and valvular insufficiency (48 percent of patients with trivial or less valvular insufficiency at last follow-up for CryoValve SG versus 30 percent for CryoValve) in patients who received the CryoValve SG for RVOT reconstruction as compared to the conventionally processed valve. Valvular insufficiency occurs when the valve leaflets do
'/>"/>

SOURCE CryoLife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
2. European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder
3. Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing
4. Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
5. Trubion Pharmaceuticals Announces Presentation of Positive TRU-015 and SBI-087 Data at the 2008 Annual European Congress of Rheumatology Meeting
6. Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections
7. Inspires Phase 3 CF Trial, Using PARIs Nebulizer & Compressor, Shows Positive Top-Line Results
8. Positive Phase I/II Data of IDX899 Confirm Potent Antiviral Activity and Favorable Safety Profile in Treatment-Naive HIV-Infected Patients
9. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
10. Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus
11. Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/bkw8kk/pharmaceutical ) ... Market in North America 2015-2019" report to their ... North America to grow at a ... International regulations regarding safe drug delivery are enforced ... fuels adoption of sustainable packaging. Various raw materials such ...
(Date:7/6/2015)... Hologic, Inc. (NASDAQ: HOLX ) announced ... results for the third quarter of fiscal 2015 on ... conjunction with the release, management will host a conference ... Interested participants may listen to the call by ... ) or 719-325-4804 (for international callers) and referencing access ...
(Date:7/6/2015)... 29, 2015 Research and ... "Pharmaceutical Grade Sodium Chloride Market by Applications, by ... report to their offering. The pharmaceutical grade ... of 6.9% between 2014 and 2019 in terms of ... KT by 2019. The report on Pharmaceutical ...
Breaking Medicine Technology:North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 3Hologic to Announce Financial Results for the Third Quarter of Fiscal 2015 on Wednesday, July 29, 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3
... DIEGO and INDIANAPOLIS, June 24, 2011 Eli ... results from an analysis designed to evaluate the cost-effectiveness of ... long-acting insulin analog (LAIA). The analysis indicated ... experience frequent hypoglycemia, insulin lispro premixed insulin analogs are likely ...
... SAN and NYSE: SNY ) announced today ... intensified insulin regimens added to oral therapy for uncontrolled ... including Lantus® (insulin glargine [rDNA origin] injection) and Apidra® ... compared to premixed insulin with less hypoglycemia and improvement ...
Cached Medicine Technology:Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S. 2Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S. 3Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S. 4Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S. 5Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S. 6Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S. 7Sanofi Announces Positive Results from the "All to Target" Study Evaluating Two Lantus® and Apidra® Regimens Versus Premixed Regimen 2Sanofi Announces Positive Results from the "All to Target" Study Evaluating Two Lantus® and Apidra® Regimens Versus Premixed Regimen 3Sanofi Announces Positive Results from the "All to Target" Study Evaluating Two Lantus® and Apidra® Regimens Versus Premixed Regimen 4Sanofi Announces Positive Results from the "All to Target" Study Evaluating Two Lantus® and Apidra® Regimens Versus Premixed Regimen 5Sanofi Announces Positive Results from the "All to Target" Study Evaluating Two Lantus® and Apidra® Regimens Versus Premixed Regimen 6
(Date:7/7/2015)... ... July 07, 2015 , ... Clarion ... labels, has been featured in the latest issue of In Compliance Magazine, a ... In Compliance delivers the latest news, standards updates, technical explanations and guidance, ...
(Date:7/6/2015)... ... 06, 2015 , ... For over twenty years, Doctors on Liens ... Throughout the company’s history the goal has been to be a comprehensive network of ... And while Doctors on Liens has certainly achieved that goal, the addition of ...
(Date:7/6/2015)... ... July 06, 2015 , ... “ TapGlance ” was ... the latest and coolest applications on the market for iOS, Android, and Windows. Joe ... with viewers how this interior design app helps users visualize what rooms will look ...
(Date:7/6/2015)... ... July 06, 2015 , ... Acara Partners, a leading business ... of its complimentary educational webinar series for the summer of 2015. ... for their clients through targeted marketing, sales, digital communications, branding and business development ...
(Date:7/6/2015)... ... July 06, 2015 , ... Understanding the new ICD-10 ... is leading the transition. ADVOCATE, the only 100% radiology, revenue cycle management company ... for ICD-10. The ten tips are timely and relevant guidelines to help radiology ...
Breaking Medicine News(10 mins):Health News:Standards Considerations for Laser Safety Labels from Clarion Safety Systems Featured in In Compliance Magazine 2Health News:Standards Considerations for Laser Safety Labels from Clarion Safety Systems Featured in In Compliance Magazine 3Health News:Standards Considerations for Laser Safety Labels from Clarion Safety Systems Featured in In Compliance Magazine 4Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 3Health News:Create a Space with TapGlance, a Revolutionary Interior Design Application 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2
... ... Medicine, SACRAMENTO, Calif., March 10 ... U.S. employment opportunities for,veterinarians are expected to increase faster than the overall ... 700 new veterinarians per year to keep up with retirement and the,ever-growing ...
... 100 Latino leaders in California participated, MANHATTAN BEACH, ... largest ethnic group by 2011 and the majority of,California,s ... in,California is uninsured, the highest rate among all ethnic ... thing politicians are discussing,with regard to the Latino community ...
... model for human malignant mesothelioma (MM) that will provide ... new directions for design of therapeutic strategies. The research, ... Cancer Cell, may eventually lead to a substantially improved ... MM is an aggressive cancer originating from the mesothelial ...
... Creates Innovative, Inviting, Child-Friendly Online Information Source for ... Healthcare Professionals ... http://www.searchhope.org , LOS ... companies, has created an innovative, inviting,child-friendly web-based portal that allows sick ...
... who do not comply with treatment instructions for osteoporosis ... likely to suffer further fractures, which seriously affects their ... to provide support to these patients and address their ... guidelines drawn up, according to lead researcher Professor Cyrus ...
... shuttle Endeavor blasts off on March 11, some ... from Arizona State Universitys Biodesign Institute. , The ... part of the STS-123 space shuttle Endeavor mission. ... Nickerson, PhD, project leader and scientist in the ...
Cached Medicine News:Health News:Shortage Creates Increased Job Prospects in Veterinary Medicine 2Health News:Shortage Creates Increased Job Prospects in Veterinary Medicine 3Health News:New Survey Shows Solutions to Improve Latinos' Access to Health Care in California 2Health News:Mouse model for mesothelioma reproduces human disease 2Health News:Siegel+Gale Designs New 'HOPE Portal' for Childrens Hospital Los Angeles 2Health News:Siegel+Gale Designs New 'HOPE Portal' for Childrens Hospital Los Angeles 3Health News:Make or break time for osteoporosis treatment 2Health News:Microscopic 'astronauts' to go back in orbit 2Health News:Microscopic 'astronauts' to go back in orbit 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: